3 years ago
Perspectum Raises $36M in Series C Funding to Advance Medical Imaging Tools
Perspectum, a UK-based precision health company, has secured $36 million in its first close of Series C funding, led by Oppenheimer Holdings
The company plans to utilize the funds to accelerate its product pipeline for multiorgan inflammatory conditions and oncology
Perspectum aims to empower patients and clinicians with advanced imaging and genetics for precision medicine, enabling early detection, diagnosis, and targeted treatment
The company has offices in the US, the UK, Portugal, and Singapore.
ProblemHealthcare
"making medical imaging tools more effective"
Solution
"developing medical imaging tools for clinicians to diagnose and treat chronic metabolic diseases, multi-organ pathology, and cancer"